BN
|
BusinessAI Desk1 views

Meta $375M Verdict, OpenAI Sora Shutdown, US Shutdown Talks, Merck $6.7B Deal

Meta was ordered to pay $375 million for failing to protect children on its platforms and plans to appeal. OpenAI is discontinuing its Sora app to reduce costs and is raising $10 billion in funding. U.S. negotiators are nearing a deal to end the partial government shutdown, with Delta suspending congressional services due to the impasse. Merck announced a $6.7 billion acquisition of Terns Pharmaceuticals to expand its portfolio ahead of a patent expiration. These events underscore significant legal, technological, and fiscal developments in the business sector.

Ad slot
Meta $375M Verdict, OpenAI Sora Shutdown, US Shutdown Talks, Merck $6.7B Deal

Meta ordered to pay $375 million in child safety case, OpenAI discontinues Sora to reduce costs, and U.S. lawmakers near shutdown deal as Merck buys Terns for $6.7 billion.

Meta Loses Child Safety Trial

  • A New Mexico jury found Meta liable for violating the state's unfair practices act by not safeguarding children on Facebook and Instagram, awarding $375 million in damages. Meta spokesperson said they will appeal the verdict.
  • Separately, AI startup Anthropic sought a court injunction against the Defense Department's ban on its products, with a judge questioning the Pentagon's motives.

OpenAI Discontinues Sora App

  • OpenAI announced it is shutting down its Sora short-form video app, which had rapid adoption, to cut expenses as it prepares for a potential public offering.
  • CFO Sarah Friar confirmed the company is raising an additional $10 billion from investors to support its operations.

U.S. Shutdown Negotiations Advance

  • Senate Republicans and the White House are close to an agreement to fund the Department of Homeland Security, though part of the ICE budget remains unresolved.
  • Delta Air Lines suspended airport escort services for Congress members and staff, citing disruptions from the partial government shutdown.

Merck's $6.7 Billion Acquisition

  • Merck, based in New Jersey, agreed to acquire Terns Pharmaceuticals for $6.7 billion to strengthen its drug portfolio before the 2028 expiration of Keytruda's patent protection.
  • Terns shares surged over 5% pre-market, while Merck's stock remained stable.
Ad slot
Ad slot